ALK-HM101-100μg / 询价
ALK-HM101-500μg / 询价
ALK-HM101-500μgx2 / 询价
|
表达区间及表达系统(Source)
|
Recombinant Human ALK-1/ACVRL1 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Asp22-Gln118 [Accession | P37023]. |
|
分子量大小(Molecular Weight)
|
The protein has a predicted MW of 11.5 kDa. Due to glycosylation, the protein migrates to 25-30 kDa based on Bis-Tris PAGE result. |
|
纯度(Purity)
|
> 95% as determined by Bis-Tris PAGE |
|
内毒素(Endotoxin)
|
Less than 1 EU per μg by the LAL method. |
|
制剂(Formulation)
|
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
|
重构方法(Reconstitution)
|
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions. |
|
存储(Storage)
|
-20 to -80°C for 12 months as supplied from date of receipt. |
Recombinant Human ALK-1/ACVRL1 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Asp22-Gln118 [Accession | P37023].
The protein has a predicted MW of 11.5 kDa. Due to glycosylation, the protein migrates to 25-30 kDa based on Bis-Tris PAGE result.
> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Less than 1 EU per μg by the LAL method.
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.
-20 to -80°C for 12 months as supplied from date of receipt.
-80°C for 3 months after reconstitution.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Activin receptor-like kinase 1 (ALK1)-mediated endothelial cell signalling in response to bone morphogenetic protein 9 (BMP9) and BMP10 is of significant importance in cardiovascular disease and cancer. Structural analyses reveal a tripartite recognition mechanism that defines BMP9 and BMP10 specificity for ALK1, and predict that crossveinless 2 is not an inhibitor of BMP9, which is confirmed by experimental evidence.
ACVRLK1; ORW2; ALK1; ALK-1; EC 2.7.11; HHT; HHT2; SKR3; TSR-I; ACVRL1; Activin RLI;Activin RL1
(1) Salmon RM, Guo J, Wood JH, Tong Z, Beech JS, Lawera A, Yu M, Grainger DJ, Reckless J, Morrell NW, Li W. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms. Nat Commun. 2020 Apr 1;11(1):1621. doi: 10.1038/s41467-020-15425-3. PMID: 32238803; PMCID: PMC7113306.
ALK-HM101-100μg / 询价
ALK-HM101-500μg / 询价
ALK-HM101-500μgx2 / 询价
| 货号* | 规格* | 名称 | 数量* | |
|---|---|---|---|---|
| 货号* | 形态* | 批号* | |
|---|---|---|---|
| 货号* | 形态* | 批号* | |
|---|---|---|---|
| 货号* | 批号* | |
|---|---|---|
| 货号* | 规格* | 批号* |
|---|---|---|
| Buffer 货号* | Buffer 规格* | Buffer 批号* |
|---|---|---|
| 货号* | 批号* | |
|---|---|---|